Report copyright - Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: The Toronto experience
Please pass captcha verification before submit form
Please pass captcha verification before submit form